According to a market report by Lucintel, the future of the global clinical trial imaging market looks promising with opportunities in the pharmaceutical company, biotechnology company, medical device manufacturer, contract research organization, academic and government research institute markets. The global clinical trial imaging market is expected to reach an estimated $2 billion by 2030, at a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are increasing number of CROs, significantly growing pharmaceutical and biotechnology industries, and increasing R&D spending to discover drugs and therapies.
A more
than 150-page report to understand trends, opportunity and forecast in global clinical
trial imaging market to 2030 by product & services (software and services),
modality (computed tomography, magnetic resonance imaging, ultrasound, positron
emission tomography, X-ray, and echocardiography), therapeutic area (oncology,
infectious diseases, neurology, CVS, endocrinology, and immunological
disorder), end use (pharmaceutical companies, biotechnology companies, medical
device manufacturer, contract research organizations, academic and government
research institutes, and others),and region (North America, Europe, Asia
Pacific, and the Rest of the World).
Lucintel
forecasts that computed tomography will remain the largest segment over the
forecast period due to including the increasing presence of contract research
organizations (CROs) and rising research and development investments.
Within
this market, pharmaceutical companies will remain the largest segment due to
increasing demand for new treatments and medications aimed at addressing
chronic diseases.
Download
sample by clicking on clinical
trial imaging market.
North
America is expected to witness highest growth over the forecast period due to
the presence of big outsourcing companies and an increase in R&D in the
region. various factors such as the increasing geriatric population along with
growing chronic diseases are projected to drive the market in north America. North
America also performs the maximum number of clinical trials.
ICON,
Biotelemetry, Medpace Holdings, Biomedical Systems Corporation, Bioclinica,
IXICO, Resonance Health, Radiant Sage, Intrinsic Imaging, Cardiovascular
Imaging Technologies are the major suppliers in the clinical trial imaging market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Hermetic Reciprocating Refrigerator Compressor Market
Hybrid & Electric Vehicle Fuse Market
Motor for Humanoid Robot Market
Overhead Travelling Cleaner (OHTC) Market
No comments:
Post a Comment